Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04018248
Title BR101801 in Adult Patients With Advanced Hematologic Malignancies( Phase I)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boryung Pharmaceutical Co., Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
National Cancer Center Goyang-si Gyeonggi-do Korea, Republic of Details
Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do Korea, Republic of Details
Chonnam National University Hwasun Hospital Hwasun Jeollanam-do Korea, Republic of Details
Inje University Busan Paik Hospital Busan Korea, Republic of Details
Asan Medical Center Seoul Korea, Republic of Details
Samsung Medical Center Seoul Korea, Republic of Details
Seoul national university hospital Seoul Korea, Republic of Details
Severance Hospital, Yonsei University Health System Seoul Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field